Andere Sprachen Regencell Bioscience Holdings Limited

Aktien

A3CY32

KYG7487R1002

RGC

Biotechnologie

Markt geschlossen - Nasdaq Andere Börsenplätze 21:00:00 13.03.2026			% 5 Tage	Veränd. 1. Jan.
23,23 ^USD	-3,21 %		-0,51 %	+10,62 %

31.10.25	Regencell Bioscience Holdings Limited veröffentlicht Geschäftsergebnisse für das am 30. Juni 2025 beendete Gesamtjahr	CI
31.10.25	Regencell Bioscience Holdings Limited: Wirtschaftsprüfer äußert Zweifel an Fortbestand des Unternehmens	CI

Andere Sprachen

04.03.	Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
31.10.25	Regencell Bioscience Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2025
31.10.25	Regencell Bioscience Holdings Limited Auditor Raises 'Going Concern' Doubt
22.09.25	Regencell Bioscience Holdings Limited(NasdaqCM:RGC) added to S&P Global BMI Index
30.06.25	Regencell Bioscience Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2024
30.06.25	Regencell Bioscience Holdings Limited Announces Board Changes, Effective June 30, 2025
27.06.25	El milagro de las hierbas : esta acción sube un 20.000% en un año sin vender nada
25.06.25	Top Premarket Gainers
23.06.25	Top Premarket Decliners
20.06.25	Top Premarket Decliners
18.06.25	Top Premarket Decliners
17.06.25	Top Premarket Gainers
17.06.25	Regencell Bioscience Extends Gains Pre-Bell Tuesday Following 276% Surge Monday
16.06.25	Top Premarket Gainers
02.06.25	Regencell Bioscience Approves 38-For-One Forward Stock Split
18.03.25	Top Premarket Gainers
25.10.24	Regencell Bioscience Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2024
29.07.24	Top Premarket Decliners
25.07.24	Top Premarket Decliners
24.07.24	Top Premarket Gainers
20.06.24	Regencell Bioscience : Announces First Half 2024 Financial Results Form 6 K
02.01.24	Regencell Bioscience : Resignation of Yi-Chung Chao as Director - Form 6-K
15.12.23	Regencell Bioscience : Form of Letter of Lock-up Undertaking - Form 6-K
27.10.23	Regencell Bioscience Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023
15.06.23	Regencell Bioscience : Announces First Half 2023 Management Financial Results - Form 6-K